The journal Diabetes Care this month has a fascinating study about basal-bolus insulin therapy for T2DM, titled Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. The authors compared two algorithms for adjusting mealtime rapid-acting (bolus) insulin and background (basal) insulin in 273 patients with type 2 diabetes over a period of 24 weeks. The simple algorithm group was provided set doses of bolus...


Top 8 Low-Carb Mistakes
What Your Feet Say About Your Health
7 Unusual Treatments for Diabetic Foot Pain
The Facts on Diabetic Neuropathy